Sunitinib Induced Thrombotic Thrombocytopenic Purpura in addition to Severe Hypothyroidism: A Case Report and Review of the Literature

Introduction. Sunitinib malate is an oral multitargeting tyrosine kinase inhibitor approved for the first line treatment of metastatic renal cell carcinoma. Sunitinib administration is associated with several adverse events including fatigue, diarrhea, skin toxicity, hypothyroidism, and cytopenia. H...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: El Dika, Imane, Mukherji, Deborah, Temraz, Sally, Assi, Rita, Shamseddine, Ali
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2014
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4202279/
https://ncbi.nlm.nih.gov/pubmed/25349620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/958414
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars